KEMODOXIN
Indication : KEMODOXIN® is indicated for regression in disseminated neoplastic conditions such as acute leukemia, Wilms tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, lung cancer, Hodgkin’s disease and non-Hodgkin’s lymphoma, bronchogenic carcinoma, and gastric carcinoma. Compositions : Each mL contain Doxorubicin hydrochloride 2 mg […]